Advertisement
Advertisement

GOSS

GOSS logo

Gossamer Bio, Inc. Common Stock

0.18
USD
Sponsored
0.00
-0.22%
Aug 07, 15:59 UTC -4
Closed
exchange

Pre-Market

0.18

0.00
+0.56%

Gossamer Bio, Inc. Common Stock Profile

About

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.

Info & Links

CEO

Faheem Hasnain

Headquarters

3115 Merryfield Row, Suite 120
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.gossamerbio.com

Auditor

Ernst & Young LLP

Share holders

33

Employees

162

Gossamer Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

87.50M

Enterprise Value

245.24M

Enterprise Value/EBITDA(ttm)

-1.35

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.75

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-324.82%

Profit Margin(ttm)

-328.35%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-254.33%

Return on Assets(ttm)

-96.10%

Income Statement

Revenue(ttm)

55.54M

Revenue Per Share(ttm)

0.24

Gross Profit(ttm)

55.54M

EBITDA(ttm)3

-182.16M

Net Income Available to Common(ttm)

-180.40M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

2.04

52-Week Change

-89.89%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

234.70M

Dividend Yield

0.00%

Float4

225.92M

% Held by Insiders

3.74%

% Held by Institutions

81.23%

Balance Sheet

Total Cash(mrq)

99.22M

Total Cash Per Share(mrq)

0.42

Total Debt(mrq)

198.76M

Total Debt/Equity(mrq)

-123.09%

Current Ratio(mrq)

2.20%

Quick Ratio(mrq)

2.20%

Book Value Per Share(mrq)

-0.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.17

Free Cash Flow(ytd)

-38.72M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement